Ranexa
Product Images NDC 61958-1001

Product Visual Gallery

This gallery contains 3 technical images submitted to the FDA as part of the official labeling for Ranexa (NDC 61958-1001). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Gilead Sciences, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Chemical Structure (Ranexa 01)

Chemical structure of Ranexa (ranolazine), showing the molecular arrangement with various functional groups including aromatic rings, amide, and ether linkages.*

FDA Label Image

Principal Display Panel (500 mg Label)

Ranexa 500 mg (ranolazine extended-release tablets) packaging label showing a count of 60 tablets. It includes storage instructions, manufacturer information for Gilead Sciences, Inc., and Rx only designation. The label also displays the NDC 61958-1001-1 and a barcode.*

FDA Label Image

Principal Display Panel (1000 mg Label)

Label for Ranexa (ranolazine extended-release tablets) 1000 mg, containing 60 tablets, manufactured by Gilead Sciences, Inc. The label includes storage instructions and a barcode, with the NDC number 61958-1002-1.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.